OnDemand - Visiting Professor in Academic Global Ophthalmology - June 2024 - Featuring Malik Kahook, MD [NON-CME]

In this series, we welcome influential ophthalmologists from around the country and the world to speak at Wills Eye Hospital for the benefit of residents and practicing ophthalmologists. Presentations and lectures include clinical and non-clinical content, and reflections on each guest's professional journey. 

This series is not certified for CME credit. 

Malik Y. Kahook, MD is Professor of Ophthalmology and The Slater Family Endowed Chair in Ophthalmology at the University of Colorado School of Medicine. He is Vice Chair of Translational Research and serves as chief of the glaucoma service and co-director of the glaucoma fellowship at the University of Colorado Eye Center.

Dr. Kahook has authored over 400 peer-reviewed manuscripts, abstracts, and book chapters, and is editor of Essentials of Glaucoma Surgery, MIGS: Advances in Glaucoma Surgery, the free online wiki www.keogt.com and the seminal textbook of glaucoma Chandler and Grant’s Glaucoma. He was named New Inventor of the Year for the University of Colorado in 2009 and Inventor of the Year for 2010.

Dr. Kahook has also received the American Glaucoma Society Innovator Award (2020), the American Academy of Ophthalmology Achievement Award in 2011, the American Academy of Ophthalmology Senior Achievement Award in 2017, the American Academy of Ophthalmology Secretariat Award (2014), the Ludwig Von Sallmann Clinician-Scientist Award (ARVO) in 2013 and was ranked second on the 40 under 40 Ophthalmology Power List (2015).  He was named to the top ten list of The Ophthalmologist Power 100 List in 2020. 

Dr. Kahook has filed for over 150 patents, with over 50 granted patents licensed by companies including New World Medical, Alcon, Aurea Medical, and SpyGlass Pharma for development and commercialization. Several of his devices are currently in human trials or available globally for clinical use including the Kahook Dual Blade from New World Medical and the Harmoni modular intraocular lens system from ClarVista Medical which was acquired by Alcon. 

Dr. Kahook is a member of Orbis International’s Board of Directors and Chairs the Orbis Medical Advisory Committee.   He is a consultant to the Food and Drug Administration’s Ophthalmic Device Division.

Mitigation of Relevant Financial Relationships

In compliance with the Standards for Integrity and Independence in Accredited Continuing Education set by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Wills Eye Hospital that the information presented at CME activities will be commercially unbiased and based upon clinical and scientific evidence. To help participants make judgments about the presence of commercial bias, Wills Eye Hospital provides information that all individuals in a position to control the content of a CME activity (including faculty, planners, reviewers or others) have disclosed about all financial relationships they have with ineligible companies. All relevant financial relationships have been mitigated.

Ineligible companies are companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company. The CME activity staff at Wills Eye Hospital report no financial relationships with ineligible companies.